scispace - formally typeset
L

Lucia Riccardi

Researcher at Harvard University

Publications -  7
Citations -  2752

Lucia Riccardi is an academic researcher from Harvard University. The author has contributed to research in topics: Angiogenesis & Vascular endothelial growth factor. The author has an hindex of 7, co-authored 7 publications receiving 2632 citations.

Papers
More filters
Journal ArticleDOI

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

TL;DR: The occurrence and biological significance of intratumoral lymphangiogenesis within human breast cancers after orthotopic transplantation onto nude mice are established and VEGF-C is identified as a molecular link between tumor lymphang iogenesis and metastasis.
Journal ArticleDOI

Thrombospondin-2: A potent endogenous inhibitor of tumor growth and angiogenesis

TL;DR: TSP-2 is established as a potent endogenous inhibitor of tumor growth and angiogenesis and combined overexpression of TSP-1 and T SP-2 completely prevented tumor formation.
Journal ArticleDOI

Overexpression of Thrombospondin-1 Decreases Angiogenesis and Inhibits the Growth of Human Cutaneous Squamous Cell Carcinomas

TL;DR: Findings establish TSP-1 as a potent inhibitor of angiogenesis and tumor growth in carcinomas of the skin as well as tumor cell proliferation rates in vivo and in vitro and anchorage-dependent and -independent growth in vitro.
Journal ArticleDOI

Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice.

TL;DR: It is demonstrated that TSP‐1 preferentially interfered with wound healing‐associated angiogenesis, rather than with theAngiogenesis associated with normal development and skin homeostasis, and suggested that therapeutic application of angiogenic inhibitors might potentially be associated with impaired wound vascularization and tissue repair.
Journal ArticleDOI

Activation of the Tie2 Receptor by Angiopoietin-1 Enhances Tumor Vessel Maturation and Impairs Squamous Cell Carcinoma Growth

TL;DR: An inhibitory role of Ang1/Tie2 receptor-mediated vessel maturation in SCC growth is identified and up-regulation of its antagonist, Ang2, during early-stage epithelial tumorigenesis contributes to the angiogenic switch by counteracting specific vessel-stabilizing effects of Ang 1.